Massive lymphadenopathy and airway obstruction in a child with Kawasaki disease: Success with pulse steroid therapy

Journal of Rheumatology

Volumn 25, Issue 6, 1998, Pages 1215-1217

  Shetty, Avinash K ^a   Homsi, Omar ^a,b   Ward, Kenneth ^a,b   Gedalia, Abraham ^a,c  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Pediatrics ^*

^c Division of Pediatric Rheumatology

Author keywords

Airway obstruction; Kawasaki disease; Pulse steroid therapy

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE;

AIRWAY OBSTRUCTION; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; LYMPHADENOPATHY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PULSATILE FLOW; RESPIRATORY DISTRESS; STEROID THERAPY; VASCULITIS;

AIRWAY OBSTRUCTION; ANTI-INFLAMMATORY AGENTS; CHILD, PRESCHOOL; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LYMPHATIC DISEASES; METHYLPREDNISOLONE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NECK; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031829001     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Allergy 1967;16:178-222.
2. Rowley AH, Gonzalez-Crussi F, Shulman ST. Kawasaki syndrome. Rev Infect Dis 1988;10:1-15.
3. Stamos JK, Corydon K, Donaldson J, Shulman ST. Lymphadenitis as the dominant manifestation of Kawasaki disease. Pediatrics 1994;23:525-8.
4. Burgner D, Festa M, Isaacs D. Delayed diagnosis of Kawasaki disease presenting with massive lymphadenopathy and airway obstruction. BMJ 1996;312:1471-2.
5. Newberger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324:1633-9.
6. Hsu CH, Chen MR, Hwang FY, et al. Efficacy of plasmin-treated intravenous gamma globulin for therapy of Kawasaki syndrome. Pediatr Infect Dis 1993;12:509-12.
7. Dorongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 1995;96:1057-61.
8. Melish M, Takahashi M, Shulman ST, et al. Comparison of low dose aspirin vs high dose aspirin as an adjunct to intravenous gammaglobulin in the treatment of Kawasaki syndrome [abstract]. Pediatr Res 1992;31:170A.
9. Kazi A, Gauthier M, Lebel MH, et al. Uvulitis and supraglottitis: early manifestations of Kawasaki disease. J Pediatr 1992;120:564-7.
10. Pontell J, Rosenfeld RM, Kohn B. Kawasaki disease mimicking retropharyngeal abscess. Otolaryngol Head Neck Surg 1994;110:428-30.
11. Ruef G. Mucocutaneous lymph node syndrome (Kawasaki syndrome) mimicking a suppurative parapharyngeal space infection. Helv Pediatr Acta 1988;43:307-12.
12. Murrant NJ, Cook JA, Murch SH. Acute ENT admission in Kawasaki disease. J Laryngol Otol 1990;104:581-4.
13. Brion L, Courtoy M, Bachelart D. et al. Mucocutaneous lymph node syndrome with necrotic pharyngitis. Eur J Pediatr 1980;135:111-6.
14. Korkis JA, Stillwater LB. An unusual otolaryngological problem: mucocutaneous lymph node syndrome (Kawasaki syndrome) case report. J Otolaryngol 1985;14:257-60.
15. Sundel RP, Burns JC, Baker A, Beiser A. Gamma globulin retreatment in Kawasaki disease. J Pediatr 1993;123:657-9.
16. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996;128:146-9.
17. Neudorf J. Neue therapeutische Aspekte zum Kawasaki-sundrome (KS) und eigene Erfahrungen. Infusionsther Transfusionsmed 1993;20:137-9.
18. Cremer H, Reiger C. Considerations on treatment in Kawasaki syndrome [abstract]. Presented at the Third International Kawasaki Disease Symposium; Nov 29-Dec 2, 1988; Tokyo, Japan.
19. Kijima Y, Kamiya T, Suzuki A, et al. Trial procedure to prevent an aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease. Jpn Circ J 1982:46:1239-42.
20. Kato H, Koike S, Yokoyama T. Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics 1979;63:175-9.
21. Kusakawa S. Long-term administrative care of Kawasaki disease. Acta Pediatr Jpn 1983;25:205-9.
22. Nonaka Z, Maekawa K, Okabe T. et al. Randomized controlled study of intravenous prednisolone and gammaglobulin treatment in 100 cases with Kawasaki disease. Presented at the Fifth International Kawasaki Disease Symposium; May 22-25, 1995; Fukuota, Japan.